The prognostic value of serum M30-antigen levels in patients with HBV-related acute-on-chronic liver failure

Rong CHEN,Zhu-jun CAO,Yun WANG,Xiao-gang XIANG,Bao-yan AN,Qing XIE,Hui WANG,Qing GUO

DOI: https://doi.org/10.3969/j.issn.1008-1704.2016.02.001

2016-01-01

Abstract:Objective To investigate the apoptotic level of hepatocytes in patients with chronic hepatitis B virus (HBV)infection at different stages,and to evaluate its prognostic value on HBV-related acute-on-chronic liver failure (HBV-ACLF).Methods A prospective study was carried out in 174 patients including 40 chronic hepatitis B (CHB),40 HBV-related liver cirrhosis (HBV-LC),54 HBV-ACLF patients and 40 healthy controls (HC).HBV-ACLF group were followed up for 3 months and classified into survival and death group.Apoptotic levels of hepatocytes were measured by detecting keratin-18 associated caspase-cleaved fragment,M30-antigen.Results Serum M30-antigen levels in CHB,HBV-LC and HBV-ACLF were 145.24 [interquartile range (IQR 86.31-206.39)U/L,213.42 (IQR 147.30-391 .28)U/L and 762.67 (IQR 492.45-1395.24)U/L respectively,which were significantly (P <0.01 )higher than those in HC group [60.34 (IQR 50.58-67.64 )U/L].Moreover,serum M30-antigen levels were gradually elevated as disease severity increased,reaching to peek in HBV-ACLF group,which was significantly higher (P <0.01)than those in CHB and HBV-LC group. M30-antigen level was significantly positively correlated with alanine aminotransferase (ALT ),aspartate transaminase (AST),total bilirubin (TBil),prothrombin time (PT),international normalized ratio (INR)and HBV-DNA (all P <0.01),while reversely correlated with albumin (P <0.01).More importantly,serum levels of M30-antigen in the death group [1175.18 (IQR 756.57-3224.94)U/L]were significantly (P <0.01 )higher than those in the survival group [491 .39 (IQR 264.23-657.17)U/L].Receiver operating characteristic (ROC)curve analysis demonstrated that serum M30-antigen could well predict 3-month outcome of HBV-ACLF patients,as the area under the curve (AUROC)was 0.86 (95% CI 0.75-0.96,P <0.01).Conclusion Hepatocyte apoptosis is closely associated with the disease severity of chronic HBV infection and markedly elevated in patients with HBV-ACLF.Hepatocytes apoptosis biomarker,M30-antigen,might be a potential indicator for the early prognosis of HBV-ACLF.